STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2934 by analyst upside · 2026-08-13
OMDA
Omada Health, Inc.
Healthcare · Market Cap $1B · P/E 35.6x
ANALYST PRICE TARGET
+11.9%
implied upside to consensus target
Current Price $23.84
Consensus Target $26.67
Bull Target $35.0
Bear Target $15.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
5
Hold
2
Sell
0
52-Week Low $10.28
52-Week High $26.91
YTD Return +60.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 35.6x
Forward P/E 44.9x
EPS (TTM) $0.67
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $310M
Profit Margin 1.4%
52-WEEK RANGE
52-Week Low $10.28
52-Week High $26.91
Current Price $23.84
Bear Target $15.0
Bull Target $35.0
● Now $23.84 ● Target $26.67
TRADING DATA
Avg Volume 1.3M
YTD Return +60.0%
Analyst Count 12
Consensus Buy
Upside to Target +11.9%
Last Updated 2026-08-13

ANALYST SUMMARY

Omada Health, Inc. (OMDA) is currently trading at $23.84 with a Wall Street consensus price target of $26.67, implying potential upside of 11.9% over the next 12 months. 12 analysts currently cover OMDA, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $15.0.

OMDA operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 60.0% year-to-date and is currently trading near the upper end of its 52-week range of $10.28 – $26.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OMDA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-08 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-08 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-05-08 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-08 Building track record
Needham reit
Buy → Buy 2026-05-08 20% win rate (5 calls)
Citizens ● Initiated
Market Outperform 2026-04-14 Building track record
Goldman Sachs - Reiterated
Buy → Buy 2026-04-09 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-08 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
20/30
Consensus clarity
13/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →